Buy ONCASPAR 750 UNIT PEGASPARGASE

ONCASPAR 750 Unit is a pegylated asparaginase solution used in cancer treatment. This intramuscular injection is manufactured by Servier Canada Inc. and is available in a 5ml pack size.

Strength

750 UNIT

Pack Size

5ML

Manufacturer / TM Owner

SERVIER CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

ONCASPAR 750 Unit is primarily used in the treatment of acute lymphoblastic leukemia (ALL). This medication works by reducing the levels of asparagine in the body, which certain cancer cells need to grow. It is often used as part of a combination chemotherapy regimen. Patients should consult their healthcare provider to determine if this medication is suitable for their specific condition.

Side Effects

Common effects of ONCASPAR 750 Unit may include injection site reactions, nausea, vomiting, and allergic reactions. Some patients may experience changes in blood cell counts or liver function. It is important to monitor for any signs of an allergic reaction, such as rash, itching, or difficulty breathing, and seek medical attention if these occur.

Precautions & Warnings

ONCASPAR 750 Unit should be handled with care and administered by a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before starting this treatment. Pregnant or breastfeeding women should discuss the potential risks and benefits with their doctor. Always follow the storage and handling instructions provided with the medication.

Avoid Interactions

ONCASPAR 750 Unit may interact with other medications, including those that affect the immune system or blood clotting. It is important to inform your healthcare provider about all medications you are taking, including prescription, over-the-counter, and herbal products. Alcohol and certain foods may also interact with this medication, so it is advisable to discuss any dietary restrictions with your doctor.

References

Frequently Asked Questions

ONCASPAR 750 Unit is used in the treatment of acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy regimen.

ONCASPAR 750 Unit is administered intramuscularly by a healthcare professional.

Common side effects may include injection site reactions, nausea, vomiting, and allergic reactions.

Pregnant women should discuss the potential risks and benefits of ONCASPAR 750 Unit with their healthcare provider.

Seek immediate medical attention if you experience signs of an allergic reaction, such as rash, itching, or difficulty breathing.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.